Cowealth Medical Holding Co (ROCO:4745) Research & Development: NT$17 Mil (TTM As of Dec. 2025)


ROCO:4745 Cowealth Medical Holding Co Ltd ROCO:4745
50 GF Score
Price NT$13.80
GF Value NT$13.11
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Cowealth Medical Holding Co Research & Development?

Cowealth Medical Holding Co ROCO:4745 50 Research & Development is NT$17 Mil as of Dec. 2025. GuruFocus rates ROCO:4745 with a GF Score™ of 50/100 and a GF Value™ of NT$13.11 (Fairly Valued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Cowealth Medical Holding Co's Research & Development for the three months ended in Dec. 2025 was NT$5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$17 Mil.

Cowealth Medical Holding Co  (ROCO:4745) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cowealth Medical Holding Co Research & Development Related Terms

Cowealth Medical Holding Co Research & Development Historical Data

* Premium members only.

The historical data trend for Cowealth Medical Holding Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cowealth Medical Holding Co Research & Development Chart

Cowealth Medical Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 12.36 13.96 16.70 16.58

Cowealth Medical Holding Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.66 2.87 0.41 7.81 5.50
ROCO:4745
50GF Score
Cowealth Medical Holding Co Ltd ROCO:4745
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cowealth Medical Holding Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$17 Mil mean?
Cowealth Medical Holding Co (ROCO:4745) has a Research & Development of NT$17 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Cowealth Medical Holding Co and its competitors.
Is Cowealth Medical Holding Co's Research & Development too high?
Cowealth Medical Holding Co's current Research & Development is NT$17 Mil. Overall, Cowealth Medical Holding Co has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cowealth Medical Holding Co's Research & Development compare to ABT and SYK?
Cowealth Medical Holding Co's Research & Development of NT$17 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cowealth Medical Holding Co and its competitors. Cowealth Medical Holding Co's current Research & Development is NT$17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cowealth Medical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Cowealth Medical Holding Co (ROCO:4745) is currently considered Fairly Valued. The stock's GF Value™ is NT$13.11, compared to a current price of NT$13.80 — trading 5.3% above its estimated fair value. The current Research & Development is NT$17 Mil. Cowealth Medical Holding Co's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cowealth Medical Holding Co (ROCO:4745), the current Research & Development is NT$17 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cowealth Medical Holding Co (ROCO:4745) Overvalued in 2026?

Based on GuruFocus' analysis, Cowealth Medical Holding Co stock appears to be overvalued. The current stock price of NT$13.80 is trading 5.3% above its estimated GF Value™ of NT$13.11. GuruFocus considers Cowealth Medical Holding Co to be Fairly Valued.

Key valuation signals for ROCO:4745:

  • Research & Development: NT$17 Mil
  • GF Value™: NT$13.11 vs. price of NT$13.80 (5.3% above fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the ROCO:4745 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cowealth Medical Holding Co Business Description

Address North Sound Road, Suite 102, Cannon Place, P.O. Box 712, George Town, Grand Cayman, CYM, KY1-9006
Cowealth Medical Holding Co Ltd is mainly involved in trading medical equipment, reagents, and spare parts. Its wide range of solutions includes refined management services tailored for in-vitro diagnostic products, reagents, and consumables, an integrated platform designed for decision-making and analysis, commercialization of achievements in medical science and technology, a Multi-Channel Coaxial Time Audio Video Imaging Platform (MCCTAVIP), and an AI-assisted system for clinical diagnosis. The Group has two reportable segments: Segment A, which generates maximum revenue and sells equipment, and Segment B, which sells reagents and others. Geographically, it generates maximum revenue from China and Hong Kong, and the rest from Taiwan.
50GF Score

Get the complete analysis for ROCO:4745

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.80
Price
NT$13.11
GF Value